Abattis Bioceuticals Corp. logo

Abattis Bioceuticals Corp. (ATTBF)

Market Closed
11 Jul, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
47.78K Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
$ 0
Previous Close
Day Range
0 0
Year Range
0 0
Want to track ATTBF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ATTBF closed Friday higher at $0, an increase of 0% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, ATTBF stock gained 0%.
ATTBF is not paying dividends to its shareholders.
The last earnings report, released on Dec 31, 2016, missed the consensus estimates by -0.01%. On average, the company has fell short of earnings expectations by -0.01%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

ATTBF Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

Abattis Bioceuticals Corp. Dividends

ATTBF is not paying dividends to its shareholders.

Abattis Bioceuticals Corp. Earnings

31 Dec 2016 Date
-
Cons. EPS
-
EPS
30 Jun 2016 Date
-
Cons. EPS
-
EPS
31 Mar 2016 Date
-
Cons. EPS
-
EPS
31 Dec 2015 Date
-
Cons. EPS
-
EPS
30 Sep 2015 Date
-
Cons. EPS
-
EPS
ATTBF is not paying dividends to its shareholders.
31 Dec 2016 Date
-
Cons. EPS
-
EPS
30 Jun 2016 Date
-
Cons. EPS
-
EPS
31 Mar 2016 Date
-
Cons. EPS
-
EPS
31 Dec 2015 Date
-
Cons. EPS
-
EPS
30 Sep 2015 Date
-
Cons. EPS
-
EPS

Abattis Bioceuticals Corp. (ATTBF) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Abattis Bioceuticals Corp. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is ATTBF.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 47.78K.

Has Abattis Bioceuticals Corp. ever had a stock split?

No, there has never been a stock split.

Abattis Bioceuticals Corp. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Francesco Paolini CEO
OTC PINK Exchange
CA00258G1037 ISIN
CA Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Abattis Bioceuticals Corp. is a life sciences and biotechnology company based in Canada. It specializes in the development and licensing of natural health products, medicines, extractions, and ingredients, targeting the biological, nutraceutical, bioceutical, and cosmetic markets. Initially known as Abattis Biologix Corporation, the company underwent a rebranding to Abattis Bioceuticals Corporation in September 2012. Founded in 1997, its headquarters are situated in Vancouver, Canada. Abattis plays a vital role in the cannabinoid industry by offering enhanced nutraceuticals for pain and inflammation, as well as Health-Canada licensed services for the cannabis sector.

Products and Services

Comfort: A flagship product of Abattis, Comfort is a cannabinoid-enhanced nutraceutical designed to target pain and inflammation. This product reflects the company's focus on integrating the therapeutic potentials of cannabinoids into conventional health products, offering a natural alternative for pain management.

Health-Canada Licensed Services: Abattis provides specialized services for the cannabis industry, facilitated by its licensing under Health Canada. These services span across quality control, cultivation, extraction, and product development, catering to the rigorous compliance and product innovation needs of the cannabis market. This avenue not only underscores the company's expertise in regulatory navigation but also positions it as a key player in supporting the burgeoning cannabis industry in Canada.

Contact Information

Address: 625 Howe Street
Phone: 808 650 3007